The deal builds on an existing technology license and commercial agreement between Mediso and RS2D over the last seven years for nanoScan, a line of 3-tesla and 7-tesla MRI scanners based on cryogen-free superconducting magnet technology. In 2019, the companies also completed a technology transfer deal for the nanoScan intellectual property.
As a result of the new deal, Cameleon4 has been integrated into the nanoScan product line. Financial terms were not disclosed.
Copyright © 2021 AuntMinnie.com